|
US4829000A
(en)
|
1985-08-30 |
1989-05-09 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Reconstituted basement membrane complex with biological activity
|
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
US6236946B1
(en)
|
1995-12-13 |
2001-05-22 |
Thomas S. Scanlan |
Nuclear receptor ligands and ligand binding domains
|
|
GB9828442D0
(en)
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
|
US6280718B1
(en)
|
1999-11-08 |
2001-08-28 |
Wisconsin Alumni Reasearch Foundation |
Hematopoietic differentiation of human pluripotent embryonic stem cells
|
|
EP1148054B1
(en)
|
2000-04-21 |
2005-11-23 |
Pfizer Products Inc. |
Thyroid receptor ligands
|
|
GB0015205D0
(en)
|
2000-06-21 |
2000-08-09 |
Karobio Ab |
Bioisosteric thyroid receptor ligands and method
|
|
EP1347959A1
(de)
|
2000-12-27 |
2003-10-01 |
Bayer Aktiengesellschaft |
Indol-derivate
|
|
PE20020958A1
(es)
|
2001-03-23 |
2002-11-14 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
|
UY27224A1
(es)
|
2001-03-23 |
2002-10-31 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
|
WO2002094319A1
(en)
|
2001-05-18 |
2002-11-28 |
Kissei Pharmaceutical Co., Ltd. |
Preventive or recurrence-suppressive agents for liver cancer
|
|
DK1262177T3
(da)
|
2001-05-31 |
2006-11-20 |
Pfizer Prod Inc |
Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner
|
|
WO2002101057A1
(fr)
|
2001-06-08 |
2002-12-19 |
Dnavec Research Inc. |
Transfert genique dans des cellules souches embryonnaires de primate a l'aide d'un virus de l'immunodeficience simienne de pseudo type vsv-g utilise comme vecteur
|
|
EP1499578A2
(en)
|
2001-08-24 |
2005-01-26 |
Karo Bio Ab |
Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
|
|
JP4505228B2
(ja)
|
2002-01-10 |
2010-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
Ｒｈｏ−キナーゼ阻害剤
|
|
MXPA04007196A
(es)
|
2002-01-23 |
2005-06-08 |
Bayer Pharmaceuticals Corp |
Inhibidores de rho-quinasa.
|
|
EP1470121B1
(en)
|
2002-01-23 |
2012-07-11 |
Bayer HealthCare LLC |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
EP1471049A4
(en)
|
2002-01-30 |
2006-08-16 |
Kissei Pharmaceutical |
NEW THYROIDIAN HORMONE RECEPTOR LIGAND, MEDICINAL PREPARATIONS CONTAINING THE SAME AND USE THEREOF
|
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
|
WO2003094845A2
(en)
|
2002-05-08 |
2003-11-20 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
|
ES2273047T3
(es)
|
2002-10-28 |
2007-05-01 |
Bayer Healthcare Ag |
Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.
|
|
US20040176425A1
(en)
|
2003-01-24 |
2004-09-09 |
Washburn William N. |
Cycloalkyl containing anilide ligands for the thyroid receptor
|
|
US7557143B2
(en)
|
2003-04-18 |
2009-07-07 |
Bristol-Myers Squibb Company |
Thyroid receptor ligands
|
|
US7220815B2
(en)
|
2003-07-31 |
2007-05-22 |
E.I. Du Pont De Nemours And Company |
Sulfonated aliphatic-aromatic copolyesters and shaped articles produced therefrom
|
|
EP2929782A1
(en)
|
2004-01-23 |
2015-10-14 |
Ocata Therapeutics, Inc. |
Improved modalities for the treatment of degenerative diseases of the retina
|
|
US7794704B2
(en)
|
2004-01-23 |
2010-09-14 |
Advanced Cell Technology, Inc. |
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
|
|
WO2005123902A1
(ja)
|
2004-06-18 |
2005-12-29 |
Riken |
無血清浮遊培養による胚性幹細胞の神経分化誘導法
|
|
DK1919878T3
(da)
|
2005-07-21 |
2010-10-25 |
Hoffmann La Roche |
Pyridazinonderivater som thyroidhormonreceptoragonister
|
|
WO2007132475A1
(en)
|
2006-05-15 |
2007-11-22 |
Cadila Healthcare Limited |
Selective tr-beta 1 agonist
|
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
|
JPWO2009148170A1
(ja)
|
2008-06-06 |
2011-11-04 |
独立行政法人理化学研究所 |
幹細胞の培養方法
|
|
RU2527948C2
(ru)
|
2009-04-20 |
2014-09-10 |
Мицубиси Танабе Фарма Корпорейшн |
Новый агонист бета рецептора тиреоидного гормона
|
|
JP5787370B2
(ja)
|
2009-11-05 |
2015-09-30 |
国立研究開発法人理化学研究所 |
幹細胞の分化誘導方法
|
|
IL281453B
(en)
|
2009-11-17 |
2022-07-01 |
Astellas Inst For Regenerative Medicine |
Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
|
|
JPWO2012173207A1
(ja)
|
2011-06-14 |
2015-02-23 |
独立行政法人理化学研究所 |
網膜細胞への分化誘導方法
|
|
EP2784152B1
(en)
|
2011-11-25 |
2019-04-10 |
Sumitomo Chemical Company, Limited |
Methods for producing retinal tissue and retina-related cell
|
|
KR102278978B1
(ko)
|
2013-08-23 |
2021-07-19 |
스미또모 가가꾸 가부시끼가이샤 |
망막 조직 및 망막 관련 세포의 제조 방법
|
|
JP6518878B2
(ja)
|
2013-10-09 |
2019-05-29 |
株式会社ヘリオス |
網膜色素上皮細胞の製造方法
|
|
EP3070162B1
(en)
|
2013-11-11 |
2019-09-18 |
Sumitomo Chemical Company, Limited |
Method for producing retinal pigment epithelial cells
|
|
EP3211071B1
(en)
|
2014-10-24 |
2021-05-05 |
Sumitomo Dainippon Pharma Co., Ltd. |
Production method for retinal tissue
|
|
TWI810142B
(zh)
|
2014-10-24 |
2023-08-01 |
日商住友製藥股份有限公司 |
神經組織的製造方法
|
|
SG11201801770VA
(en)
|
2015-09-08 |
2018-04-27 |
Sumitomo Dainippon Pharma Co Ltd |
Method for producing retinal pigment epithelial cells
|
|
SG11201809201UA
(en)
|
2016-04-22 |
2018-11-29 |
Sumitomo Dainippon Pharma Co Ltd |
Method for producing retinal tissue
|
|
MY199613A
(en)
|
2016-11-25 |
2023-11-09 |
Riken |
Cell population for transplantation and method for producing same
|
|
EP3634438A4
(en)
*
|
2017-06-05 |
2021-03-03 |
The Regents of The University of California |
COMPOSITIONS FOR THE TREATMENT OF NETWORK DISEASES AND METHOD FOR THEIR MANUFACTURE AND USE
|
|
EP3656852B1
(en)
|
2017-07-20 |
2025-09-03 |
Riken |
Method for maturation of retinal tissue containing continuous epithelium
|
|
WO2022054925A1
(ja)
*
|
2020-09-11 |
2022-03-17 |
国立研究開発法人理化学研究所 |
神経網膜を含む細胞凝集体とマトリクスとを含む複合体及びその製造方法
|